share_log

Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target

Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target

Canaccord Genuity 重申买入KORU Medical Systems,维持3美元的目标股价
Benzinga ·  2023/12/07 10:36

Canaccord Genuity analyst Caitlin Cronin reiterates KORU Medical Systems (NASDAQ:KRMD) with a Buy and maintains $3 price target.

Canaccord Genuity分析师凯特琳·克罗宁重申了KORU Medical Systems(纳斯达克股票代码:KRMD)的买入并维持3美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发